Quantcast
Last updated on April 21, 2014 at 11:58 EDT

Latest Glycated hemoglobin Stories

2012-09-10 23:02:39

Patients of doctors who are more empathic have better outcomes and fewer complications, concludes a large, empirical study by a team of Thomas Jefferson University and Italian researchers who evaluated relationships between physician empathy and clinical outcomes among 20,961 diabetic patients and 242 physicians in Italy. The study was published in the September 2012 issue of Academic Medicine, and serves as a follow up to a smaller study published in the same journal in March 2011 from...

2012-08-07 22:55:50

Beth Israel Deaconess Medical Center study analyzes hemoglobin A1C levels in blacks, whites Healthcare providers should take into account differences among racial groups when using hemoglobin A1C levels to diagnose and monitor diabetes, new research from Beth Israel Deaconess Medical Center suggests. In a study published Aug. 7 in the Annals of Internal Medicine, researchers analyzed National Health and Nutrition Survey data from 2005 to 2008 to examine the association between...

2012-08-06 02:25:26

TAIPEI, Taiwan, Aug. 6, 2012 /PRNewswire-Asia/ -- TWi Pharmaceuticals, Inc., a specialty pharmaceutical company based in Taiwan, today announced its fully owned subsidiary, TWi Biotechnology, Inc. has completed a multinational phase II dose-ranging study of AC-201, an orally available IL-1 Beta modulator, in 259 patients with type II diabetes uncontrolled on up to three oral medications. In the intent-to-treat population, AC-201 showed placebo-corrected reductions in HbA1c of 0.20%,...

2012-07-25 02:31:38

RIDGEFIELD, Conn. and INDIANAPOLIS, July 25, 2012 /PRNewswire/ -- Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced the receipt of Marketing Authorization from the European Commission for Jentadueto® (linagliptin/metformin hydrochloride) tablets, a medicine combining the DPP-4 inhibitor, linagliptin (the active ingredient in Tradjenta® tablets, marketed under the trade name Trajenta® in Europe) and metformin in a single tablet taken twice daily.(1 ) The...

2012-07-22 02:20:17

NEW YORK, July 22, 2012 /PRNewswire/ -- A recent study published in the Journal of Dental Research at Columbia University College of Dental Medicine (CDM) and backed by The Jeffrey Epstein VI Foundation amongst others; found that a pre-diabetes determination can be made by simply going to the dentist. The study has huge implications for those Americans who are developing Type 2 diabetes at alarming rates. Unlike Type 1, Type 2 Diabetes is acquired, mostly from poor diet and therefore, early...

2012-07-16 06:29:49

By Katie Williams, Ivanhoe Health Correspondent (Ivanhoe Newswire) -- In the past, ancient civilizations valued spices and herbs for their mythical medicinal power. Now, new science is emerging about the protective properties of spices and herbs, and how you can turn your health around with a simple dash of seasoning to your meal. "Taste is still the number one, it´s not a surprise, the number one influencer on why we choose what we choose to eat," Wendy Bazilian, DrPH, RD, author...

2012-06-25 21:16:07

Adults who are exposed to secondhand smoke have higher rates of obesity and Type 2 diabetes than do nonsmokers without environmental exposure to tobacco smoke, a new study shows. The results will be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston. "More effort needs to be made to reduce exposure of individuals to secondhand smoke," said study co-author Theodore C. Friedman, MD, PhD, chairman of the Department of Internal Medicine at Charles R. Drew University,...

2012-06-25 21:10:18

Obese adults with poorly controlled Type 1 diabetes can better control their blood sugar by adding liraglutide, a Type 2 diabetes drug, to their insulin therapy, a new study finds. The results, which will be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston, also found that these diabetic patients lost weight and lowered their blood pressure. "These results are extremely relevant because in most patients with Type 1 diabetes, the disease is not well controlled,"...

2012-06-25 02:25:43

THE WOODLANDS, Texas, June 25, 2012 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today that LX4211, an investigational, oral, dual inhibitor of sodium glucose transporters 1 and 2 (SGLT1 and SGLT2), showed substantial, dose-dependent, statistically-significant reductions in hemoglobin A1c (HbA1c) in a Phase 2b trial in patients diagnosed with poorly-controlled type 2 diabetes who were concurrently treated with metformin, an established diabetes therapy. LX4211...

2012-06-22 16:06:30

Such interventions work best for diabetics in poorer health A new study has found that programs aimed at helping people prevent or manage diabetes are most successful if they are directed at the patient or the health care system. Programs aimed at physicians were only successful for patients with poorer diabetes control. Such interventions also work best for diabetics in poorer health than those who are managing their illness well, the study found. The study--a comprehensive review...